Table III.
Baseline characteristics of 4871 participants⁎ enrolled as of January 14, 2019.
| Variable | |
|---|---|
| Mean Age (years) | 57.1 |
| 18–35 | 526/4907 (10.7%) |
| 36–64 | 2674/4907 (54.5%) |
| ≥ 65 | 1707/4907 (34.8%) |
| Sex (Female) | 2555/4907 (52.1%) |
| New York Heart Association Class for Heart Failure | |
| Class II | 3411/4907 (69.5%) |
| Class III | 1273/4907 (25.9%) |
| Class IV | 219/4907 (4.5%) |
| Prior Myocardial Infarction | 945/4878 (19.4%) |
| Depressed left ventricular Function |
3507/4641 (75.6%) |
| Prior Stroke | 391/4878 (8.0%) |
| Angiotensin converting Enzyme inhibitor |
Reduced Ejection Fraction 1736/3506 (49.5%) | Preserved Ejection Fraction 502/1376 (36.5%) |
|---|---|---|
| Beta blocker | 2232/3506 (63.7%) | 633/1376 (46.0%) |
| Diuretic | 2593/3506 (74.0%) | 581/1376 (42.2%) |
| Aldosterone inhibitor | 1954/3506 (55.7%) | 396/1376 (28.8%) |
⁎
Since data is still being entered, denominators vary.